Clinical trial
A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and…
NCT00171093 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00171093 |
|---|---|
| Title | A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and Hypercholesterolemia |
| Official title | A 10-12 Week Multicenter, Double-blind Study to Evaluate the Efficacy and Safety of the Combination of Valsartan (320 mg) and Simvastatin (80 mg) Compared to Valsartan (320 mg) and Simvastatin (80 mg) Monotherapies in Essential Hypertension and Hypercholesterolemia |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HYPERTENSION, HYPERCHOLESTEROLEMIA |
| Intervention type | Drug |
| Interventions | valsartan + simvastatin |
| Enrollment | 369 |
| Start date | Sep 1, 2004 |
| Primary completion | Jan 1, 2006 |
| First posted | Sep 15, 2005 |
| Last update posted | Feb 23, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: